The effects of long working hours on the psychological health during COVID-19 and roles of social services
Keywords:
Long COVID, prevalence, symptoms, healthcare, COVID-19, systematic reviewAbstract
Aim: This systematic review aims to consolidate global evidence regarding the prevalence and symptomatology of Long COVID in hospitalized and non-hospitalized populations, providing insights into the long-term health effects following COVID-19 infection. Methods: A comprehensive literature search identified 194 studies involving 735,006 participants. The analysis included both hospitalized and non-hospitalized cohorts, focusing on symptom prevalence and associated health outcomes at an average follow-up of 126 days post-infection. Results: The findings reveal that 45% of COVID-19 survivors report at least one unresolved symptom, with fatigue, disturbed sleep, and breathlessness being the most frequently reported issues. Hospitalized patients exhibited a higher prevalence of persistent symptoms (52.6%) compared to non-hospitalized patients (34.5%). The review highlights significant heterogeneity in study designs, methodologies, and symptom reporting, which complicates the interpretation of Long COVID'S prevalence. Conclusion: The review underscores the urgent need for standardized data collection methods to enhance the clinical relevance of future Long COVID research. Given the high incidence of unresolved symptoms, healthcare services and policymakers must prioritize Long COVID care and explore different subtypes to ensure effective, stratified healthcare.
Downloads
References
WHO: WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/
WHO A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021: 2021
Office for National Statistics Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 6 May 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/6may2022
National Centre for Health Statistic Nearly one in five American adults who have had COVID-19 still have “Long COVID”. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm Date: 2022
Michelen M. Manoharan L. Elkheir N. et al. Characterising long COVID: a living systematic review. BMJ Global Health. 2021; 6e005427
Aiyegbusi O.L. Hughes S.E. Turner G. et al Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021; 114: 428-442
Groff D. Sun A. Ssentongo A.E. et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021; 4: e2128568
Lopez-Leon S. Wegman-Ostrosky T. Perelman C. et al More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021;https://doi.org/10.1101/2021.01.27.21250617
Nasserie T. Hittle M. Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021; 4: e2111417
Dennis A. Wamil M. Alberts J. et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021; 11e048391
Iacobucci G. Long covid: damage to multiple organs presents in young, low risk patients. BMJ. 2020; 371: m4470
Chen C. Haupert S.R. Zimmermann L. Shi X. Fritsche L.G. Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022; 226: 1593-1607
National Heart Lung, and Blood Institute Study quality assessment tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Date: 2021
Higgins J.P. Thompson S.G. Deeks J.J. Altman D.G Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560
Huntley C.C. Patel K. Bil Bushra S.-E.S. et al. Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis. ERJ Open Res. 2022; 8 (00056-2022)
Hughes S.E. Haroon S. Subramanian A. et al. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): rasch analysis.BMJ. 2022; 377e070230
Munblit D. Nicholson T. Akrami A. et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med. 2022; 10: 715-724
Raveendran A.V. Jayadevan R. Sashidharan S. Long COVID: an overview. Diabetes Metabol Syndr: Clin Res Rev. 2021; 15: 869-875
Ziauddeen N. Gurdasani D. O'Hara M.E.et al.Characteristics and impact of long covid: findings from an online survey. PLoS One. 2022; 17e0264331
National Institute for Health and Care Research A dynamic review of the evidence around ongoing Covid 19 symptoms (often called Long Covid).https://evidence.nihr.ac.uk/themedreview/living-with-covid19/Date: 2021
Davis H.E. Assaf G.S. McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38101019
Parolin Z. Lee E.K. The role of poverty and racial discrimination in exacerbating the health consequences of COVID-19. The Lan Reg Health Americas. 2022; 7100178
Tai D.B.G. Shah A. Doubeni C.A. Sia I.G. Wieland M.L. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin Infect Dis. 2020; 72: 703-706
Routen A. O'Mahoney L. Ayoubkhani D. et al. Understanding and tracking the impact of long COVID in the United Kingdom. Nat Med. 2021; 28: 11-15
Walker A.J. MacKenna B. Inglesby P. et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021; 71: e806-e814
Iwu C.J. Iwu C.D. Wiysonge C.S. The occurrence of long COVID: a rapid review. Pan Afr Med J. 2021; 38: 65
O'Mahoney, L. L., Routen, A., Gillies, C., Ekezie, W., Welford, A., Zhang, A., ... & Khunti, K. (2023). The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine, 55.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
